Cargando…

Risk Scoring System based on lncRNA Expression for Predicting Survival in Hepatocellular Carcinoma with Cirrhosis

OBJECTIVE: This study aims to explore the roles of long non-coding RNAs (lncRNAs) for predicting survival in hepatocellular carcinoma (HCC) patients with cirrhosis. METHODS: A set of lncRNAs differentially expressed between HCC patients with or without cirrhosis was identified using expression profi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ye, Jiaxiang, Li, Haixia, Wei, Jiazhang, Luo, Yue, Liu, Hongmei, Zhang, Jinyan, Luo, Xiaoling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	West Asia Organization for Cancer Prevention 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568908/ https://www.ncbi.nlm.nih.gov/pubmed/32592379 http://dx.doi.org/10.31557/APJCP.2020.21.6.1787

Ejemplares similares

lncRNA Expression-Based Risk Scoring System Can Predict Survival of Tumor-Positive Patients with Hepatocellular Carcinoma
por: Wu, Siyao, et al.
Publicado: (2021)

Long non-coding RNA-based risk scoring system predicts prognosis of alcohol-related hepatocellular carcinoma
por: Luo, Yue, et al.
Publicado: (2020)

Identification and Analysis of the Blood lncRNA Signature for Liver Cirrhosis and Hepatocellular Carcinoma
por: Xia, Qi, et al.
Publicado: (2020)

Corrigendum: Identification and Analysis of the Blood lncRNA Signature for Liver Cirrhosis and Hepatocellular Carcinoma
por: Xia, Qi, et al.
Publicado: (2021)

Identification of lncRNA biomarkers in hepatocellular carcinoma by comprehensive analysis of the lncRNA-mediated ceRNA network
por: Ye, Dingde, et al.
Publicado: (2022)

Epstein-Barr Virus Promotes Tumor Angiogenesis by Activating STIM1-Dependent Ca(2+) Signaling in Nasopharyngeal Carcinoma
por: Ye, Jiaxiang, et al.
Publicado: (2021)

LncRNA SNHG17 Contributes to Proliferation, Migration, and Poor Prognosis of Hepatocellular Carcinoma
por: Luo, Yue, et al.
Publicado: (2021)

lncRNA involvement in hepatocellular carcinoma metastasis and prognosis
por: Abbastabar, Maryam, et al.
Publicado: (2018)

LncRNA profile study reveals a three-lncRNA signature associated with the survival of patients with oesophageal squamous cell carcinoma
por: Li, Jiagen, et al.
Publicado: (2014)

Integrated Analysis of mRNA and lncRNA Expression Profiles Reveals Regulatory Networks Associated with Decompensated Cirrhosis
por: Zhang, Li, et al.
Publicado: (2022)

Immunoautophagy-Related Long Noncoding RNA (IAR-lncRNA) Signature Predicts Survival in Hepatocellular Carcinoma
por: Wang, Yulu, et al.
Publicado: (2021)

Screening prognostic markers for hepatocellular carcinoma based on pyroptosis-related lncRNA pairs
por: Wu, Tong, et al.
Publicado: (2023)

LncRNA-SVUGP2 suppresses progression of hepatocellular carcinoma
por: Hu, Jiangfeng, et al.
Publicado: (2017)

Postoperative survival analysis of hepatocellular carcinoma patients with liver cirrhosis based on propensity score matching
por: Wu, Zhaoqin, et al.
Publicado: (2022)

Identification of a novel lncRNA prognostic signature and analysis of functional lncRNA AC115619.1 in hepatocellular carcinoma
por: Gan, Binliang, et al.
Publicado: (2023)

Integrative analysis of dysregulated lncRNA-associated ceRNA network reveals potential lncRNA biomarkers for human hepatocellular carcinoma
por: Li, Chengyun, et al.
Publicado: (2020)

The effect of SNPs in lncRNA as ceRNA on the risk and prognosis of hepatocellular carcinoma
por: Mo, Han, et al.
Publicado: (2022)

Comprehensive analysis of lncRNA-mediated ceRNA networkfor hepatocellular carcinoma
por: Chen, Weiqing, et al.
Publicado: (2022)

Comprehensive analysis of lncRNA biomarkers in kidney renal clear cell carcinoma by lncRNA-mediated ceRNA network
por: Gong, Ke, et al.
Publicado: (2021)

Fucoidan Inhibits the Progression of Hepatocellular Carcinoma via Causing lncRNA LINC00261 Overexpression
por: Ma, Danhui, et al.
Publicado: (2021)

Innovative signature establishment using lymphangiogenesis-related lncRNA pairs to predict prognosis of hepatocellular carcinoma
por: Cao, Jincheng, et al.
Publicado: (2022)

Clinical significance of lncRNA-ATB expression in human hepatocellular carcinoma
por: Jang, Se Young, et al.
Publicado: (2017)

Correction: LncRNA-SVUGP2 suppresses progression of hepatocellular carcinoma
por: Hu, Jiangfeng, et al.
Publicado: (2018)

A five lncRNA signature for prognosis prediction in hepatocellular carcinoma
por: Sun, Yongqiang, et al.
Publicado: (2019)

Identification and Validation of a Prognostic lncRNA Signature for Hepatocellular Carcinoma
por: Li, Wang, et al.
Publicado: (2020)

The prognostic value of an autophagy-related lncRNA signature in hepatocellular carcinoma
por: Yang, Shiming, et al.
Publicado: (2021)

Construction of a genome instability-derived lncRNA-based risk scoring system for the prognosis of hepatocellular carcinoma
por: Huang, Dan-Ping, et al.
Publicado: (2021)

Systematic analyses of a novel lncRNA‐associated signature as the prognostic biomarker for Hepatocellular Carcinoma
por: Sui, Jing, et al.
Publicado: (2018)

LncRNA TIALD contributes to hepatocellular carcinoma metastasis via inducing AURKA lysosomal degradation
por: Wang, Yingchao, et al.
Publicado: (2023)

Epigenetic Associations between lncRNA/circRNA and miRNA in Hepatocellular Carcinoma
por: Han, Tae-Su, et al.
Publicado: (2020)

Transcriptomic Analysis of mRNA-lncRNA-miRNA Interactions in Hepatocellular Carcinoma
por: Tang, Xia, et al.
Publicado: (2019)

Seven LncRNA-mRNA based risk score predicts the survival of head and neck squamous cell carcinoma
por: Zhang, Zhi-Li, et al.
Publicado: (2017)

Construction of lncRNA-mediated ceRNA network to reveal clinically relevant lncRNA biomarkers in glioblastomas
por: Zan, Xiang-Yang, et al.
Publicado: (2019)

A Novel Nine-lncRNA Risk Signature Correlates With Immunotherapy in Hepatocellular Carcinoma
por: Nie, Ye, et al.
Publicado: (2021)

An N(6)-methyladenosine-associated lncRNA signature for predicting clinical outcome and therapeutic responses in hepatocellular carcinoma
por: Song, Danjun, et al.
Publicado: (2022)

LncRNA AK054921 and AK128652 are potential serum biomarkers and predictors of patient survival with alcoholic cirrhosis
por: Yang, Zhihong, et al.
Publicado: (2017)

Identification of Immune-Related Prognostic mRNA and lncRNA in Patients with Hepatocellular Carcinoma
por: Chen, Dan, et al.
Publicado: (2022)

An lncRNA Model for Predicting the Prognosis of Hepatocellular Carcinoma Patients and ceRNA Mechanism
por: Zhang, Hao, et al.
Publicado: (2021)

Construction of a ceRNA Network and Comprehensive Analysis of lncRNA in Hepatocellular Carcinoma
por: Wang, Lin, et al.
Publicado: (2022)

Macrophage-associated lncRNA ELMO1-AS1: a novel therapeutic target and prognostic biomarker for hepatocellular carcinoma
por: Luo, Tao, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ddjvvlr2qehjasdt5jcb19b0ut